The 2024 Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship will be held on October 18 – AIM-HI Accelerator Fund

AIM-HI Accelerator Fund shared a post on LinkedIn:

“Only 3 weeks away! The 2024 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship will be held on Friday, October 18, at the National Press Club in Washington, DC.

Register today to hear from and engage with world-class key opinion leaders in the oncology field.

We welcome the following panelists in a discussion of considerations of early-stage oncology investment during the afternoon part of the conference.
3:10-4:10 pm Session II: Investor Perspective on Innovative Oncology Companies

Moderator: Matt Tremblay, Ph.D. (Chair of AIM-HI Board, and CEO of Blackbird Laboratories)
David Greenwald, Ph.D., (VP of Business Development, Deerfield; CEO of Aviko Radiopharmaceuticals)
Beverly Lu, PhD, (Investor at Yosemite)
Marie-Claire Peakman, Ph.D. (Executive Director of Emerging Science & Innovation at Pfizer Ventures)
Fei Shen, Ph.D. (Managing Director at BI Venture Fund)

Find out the full program details and other high-profile speakers at this exciting event here.”

Source: AIM-HI Accelerator Fund/LinkedIn